At 3.9% CAGR, Middle East & Africa Microelectrode Array In Vitro Market is Projected to be Worth US$ 0.72 Million by 2031, says Business Market Insights

According to Business Market Insights' research, the Middle East & Africa microelectrode array in vitro market was valued at US$ 0.53 million in 2023 and is expected to reach US$ 0.72 million by 2031, registering a CAGR of 3.9% from 2023 to 2031. Increasing demand for microelectrode arrays in neuroscience research and microelectrode arrays with advanced features are among the critical factors attributed to drive the Middle East & Africa microelectrode array in vitro market growth.

Neuroscience research involves testing new drugs on neuronal cultures to evaluate their effects on neural activity and develop targeted treatments. Researchers utilize in vitro models to investigate a variety of neurological and neuropsychiatric diseases, including Alzheimer's disease, Parkinson's disease, and epilepsy, as well as various neurodevelopmental disorders. The increasing prevalence of such neurological disorders increases the demand for microelectrode array systems in neuroscience research. Microelectrode arrays in vitro allow for the examination of specific cellular and molecular changes related to neurological conditions, and their effects on neural functions. By measuring neural activity in vitro cell models using microelectrode arrays, researchers can assess drug compounds' ability to modulate neural activity, restore normal network function, or counteract disease-related abnormalities. This information is essential for identifying promising drug candidates at an early stage during development. With the growing utilization of microelectrode arrays in neuroscience research laboratories, market players such as Axion BioSystems, Multi-Channel Systems, and MaxWell Biosystems are adopting strategies to launch innovative products in the market. For instance, in April 2024, Axion BioSystems launched the Maestro Volt, an affordable benchtop microelectrode array system tailored for academic labs with lower throughput needs. This 6-well device, suitable for neurological and cardiovascular research, offers user-friendly features and high-quality controls associated with the company's Maestro brand. Therefore, a surge in neuroscience research for developing new drugs for neurodegenerative diseases boosts the demand for microelectrode arrays in vitro, which drives the market.

On the contrary, the high development costs of microelectrode arrays hamper the growth of Middle East & Africa microelectrode array in vitro market.

Based on product, the Middle East & Africa microelectrode array in vitro market is divided into classical MEA, multiwell-MEA, and CMOS-MEA. The multiwell-MEA segment held 67.0% market share in 2023, amassing US$ 355.02 thousand. It is projected to garner US$ 487.87 thousand by 2031 to register 4.1% CAGR during 2023-2031.

In terms of application, the Middle East & Africa microelectrode array in vitro market is segmented into cardiomyocytes, nerve, and others. The cardiomyocytes segment held 45.5% share of Middle East & Africa microelectrode array in vitro market in 2023, amassing US$ 240.84 thousand. It is anticipated to garner US$ 334.83 thousand by 2031 to expand at 4.2% CAGR during 2023-2031.

Based on country, the Middle East & Africa microelectrode array in vitro market is categorized into South Africa, the UAE, Saudi Arabia, and the Rest of Middle East & Africa. Our regional analysis states that South Africa captured 36.5% share Middle East & Africa microelectrode array in vitro market in 2023. It was assessed at US$ 193.41 thousand in 2023 and is likely to hit US$ 272.39 thousand by 2031, registering a CAGR of 4.4% during 2023-2031.

Key players operating in the microelectrode array in vitro market are Tucker Davis Technologies; SCREEN Holdings Co., Ltd.; Plexon Inc.; MaxWell Biosystems AG; Harvard Bioscience Inc.; Axion BioSystems Inc; 3Brain AG; NeuroNexus Technologies Inc.; MicroElectrodeDevices; Blackrock Microsystems, Inc.; NMI Technologietransfer GmbH; and BMSEED, among others.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com